Beijing Anzhen hospital
Beijing, Beijing Municipality, 100029, China
Location contact
Yan Yan, Dr.
PRINCIPAL_INVESTIGATOR
Zeqi Dai, PhD
CONTACT
NCT Number: NCT06486857
This study aims to validate the feasibility and accuracy of a novel gas detection method for dyslipidemia screening by analyzing the lipid profile of human breath metabolites. It explores a simple, rapid, and non-invasive method for screening dyslipidemia. The application prospects of this method are broad; it can be used not only for early screening and monitoring of dyslipidemia in hospitals and communities, providing strong support for the prevention of cardiovascular diseases, but also for the routine monitoring and treatment effectiveness evaluation of patients with hyperlipidemia, offering a scientific basis for personalized treatment plans. This study not only has profound scientific value but also provides a theoretical basis for the development of subsequent new clinical testing methods.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100029, China
Yan Yan, Dr.
PRINCIPAL_INVESTIGATOR
Zeqi Dai, PhD
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multidimensional Mass Spectrometry Technologies Based on Exhaled Metabolic Fingerprint Spectra for Dyslipidemia Detection
Time frame: within 1 week day of sample collection
Beijing Anzhen Hospital
Other
Accuracy Validation Study of a Novel Gas Detection Method for Dyslipidemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07644910
Breast Diseases, Breast Neoplasms
View Trial DetailsNCT07634510
Dyslipidemias, Lipid Metabolism Disorders
View Trial DetailsNCT06590649
Body Weight, Cardiovascular Diseases
Honolulu, Hawaii, United States
View Trial DetailsNCT06520800
Adolescent Obesity, Behavior
View Trial Details